DK2208734T3 - Levnedsmiddelmateriale til inhibering af dannelsen af osteoclast - Google Patents

Levnedsmiddelmateriale til inhibering af dannelsen af osteoclast

Info

Publication number
DK2208734T3
DK2208734T3 DK08844720.6T DK08844720T DK2208734T3 DK 2208734 T3 DK2208734 T3 DK 2208734T3 DK 08844720 T DK08844720 T DK 08844720T DK 2208734 T3 DK2208734 T3 DK 2208734T3
Authority
DK
Denmark
Prior art keywords
amino acid
milk protein
protein fraction
food material
milk
Prior art date
Application number
DK08844720.6T
Other languages
English (en)
Inventor
Atsushi Serizawa
Yoshikazu Morita
Daisuke Uetsuji
Aiko Ono
Hiroaki Matsuyama
Satoshi Higurashi
Original Assignee
Megmilk Snow Brand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megmilk Snow Brand Co Ltd filed Critical Megmilk Snow Brand Co Ltd
Application granted granted Critical
Publication of DK2208734T3 publication Critical patent/DK2208734T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/261—Animal proteins
    • A21D2/263—Animal proteins from dairy products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/068—Particular types of cheese
    • A23C19/08—Process cheese preparations; Making thereof, e.g. melting, emulsifying, sterilizing
    • A23C19/082—Adding substances to the curd before or during melting; Melting salts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK08844720.6T 2007-11-01 2008-10-28 Levnedsmiddelmateriale til inhibering af dannelsen af osteoclast DK2208734T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007285423 2007-11-01
PCT/JP2008/003071 WO2009057287A1 (ja) 2007-11-01 2008-10-28 破骨細胞形成抑制用食品素材

Publications (1)

Publication Number Publication Date
DK2208734T3 true DK2208734T3 (da) 2012-05-14

Family

ID=40590694

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08844720.6T DK2208734T3 (da) 2007-11-01 2008-10-28 Levnedsmiddelmateriale til inhibering af dannelsen af osteoclast

Country Status (13)

Country Link
US (1) US20100234296A1 (da)
EP (1) EP2208734B1 (da)
JP (1) JPWO2009057287A1 (da)
KR (1) KR20100100845A (da)
CN (1) CN101842385B (da)
AT (1) ATE542832T1 (da)
AU (1) AU2008320277A1 (da)
CA (1) CA2704092C (da)
DK (1) DK2208734T3 (da)
ES (1) ES2378213T3 (da)
NZ (1) NZ585092A (da)
PT (1) PT2208734E (da)
WO (1) WO2009057287A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY160058A (en) * 2007-11-01 2017-02-15 Megmilk Snow Brand Co Ltd Bone-reinforcing food material
JPWO2009057282A1 (ja) * 2007-11-01 2011-03-10 雪印乳業株式会社 骨吸収抑制用食品素材
JPWO2009057281A1 (ja) * 2007-11-01 2011-03-10 雪印乳業株式会社 骨芽細胞分化促進及び破骨細胞分化抑制用食品素材
JP2012077015A (ja) * 2010-09-30 2012-04-19 Snow Brand Milk Products Co Ltd 皮膚コラーゲン産生促進剤
KR101748907B1 (ko) * 2011-01-26 2017-06-19 유키지루시 메그밀크 가부시키가이샤 감각 개선제
JP5969225B2 (ja) * 2012-03-09 2016-08-17 雪印メグミルク株式会社 骨強化剤

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE901672A (fr) * 1985-02-07 1985-08-07 Oleofina Sa Procede de purification de proteines du lait et de ses derives.
IE61701B1 (en) * 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
JPH0725800B2 (ja) 1987-04-10 1995-03-22 雪印乳業株式会社 硫酸エステル化物を用いて乳からラクトフエリンを分離、精製する方法
FR2616628B1 (fr) * 1987-06-19 1989-09-29 Entremont Sa Procede pour extraire des proteines du lactoserum par adsorption et elution
JP3160862B2 (ja) 1990-11-15 2001-04-25 雪印乳業株式会社 骨強化食品、飼料及び医薬
JP3092874B2 (ja) 1991-12-26 2000-09-25 雪印乳業株式会社 乳清由来の骨芽細胞増殖・骨強化画分及び該画分を含有する骨強化食品、飼料、薬品類
JP3604159B2 (ja) 1992-05-07 2004-12-22 雪印乳業株式会社 乳清由来の骨芽細胞増殖促進及び骨強化因子ならびに該因子を含有せしめた骨強化食品、医薬および飼料
JPH05202098A (ja) 1992-01-29 1993-08-10 Snow Brand Milk Prod Co Ltd 乳質原料から生理活性物質の製造法
JP3112637B2 (ja) * 1994-09-30 2000-11-27 雪印乳業株式会社 骨強化剤
JP3929088B2 (ja) * 1996-06-20 2007-06-13 雪印乳業株式会社 骨形成促進及び骨吸収防止剤
US6649590B2 (en) * 2000-06-09 2003-11-18 Snow Brand Milk Products Co., Ltd. Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
JP2001346519A (ja) * 2000-06-09 2001-12-18 Snow Brand Milk Prod Co Ltd 乳塩基性シスタチン高含有画分及びその分解物の製造方法
US7169559B2 (en) * 2002-05-13 2007-01-30 Fonterra Corporate Research and Development Ltd. LDL receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
FR2841747B1 (fr) * 2002-07-02 2004-08-20 Cie Laitiere Europeenne Isolat de proteines de lait et procede pour sa preparation
JP2004115509A (ja) * 2002-09-05 2004-04-15 Snow Brand Milk Prod Co Ltd 破骨細胞分化抑制因子産生促進剤
JP2004238320A (ja) * 2003-02-05 2004-08-26 Snow Brand Milk Prod Co Ltd 骨吸収抑制剤
JP4536341B2 (ja) * 2003-08-15 2010-09-01 雪印乳業株式会社 骨形成促進剤
US20060286084A1 (en) * 2003-09-30 2006-12-21 Yoshikazu Morita Agent for promoting osteogenesis and/or inhibiting bone resorption
EP1937298A4 (en) * 2005-10-14 2009-11-11 Auckland Uniservices Ltd USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES

Also Published As

Publication number Publication date
ES2378213T3 (es) 2012-04-10
CA2704092A1 (en) 2009-05-07
ATE542832T1 (de) 2012-02-15
CA2704092C (en) 2017-06-20
NZ585092A (en) 2013-03-28
US20100234296A1 (en) 2010-09-16
PT2208734E (pt) 2012-03-29
CN101842385B (zh) 2013-11-27
JPWO2009057287A1 (ja) 2011-03-10
EP2208734A4 (en) 2010-11-03
WO2009057287A1 (ja) 2009-05-07
AU2008320277A1 (en) 2009-05-07
KR20100100845A (ko) 2010-09-15
EP2208734A1 (en) 2010-07-21
CN101842385A (zh) 2010-09-22
EP2208734B1 (en) 2012-01-25

Similar Documents

Publication Publication Date Title
PH12019500644A1 (en) Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
WO2007016538A3 (en) Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
DK2208734T3 (da) Levnedsmiddelmateriale til inhibering af dannelsen af osteoclast
WO2008036932A3 (en) Compositions and methods comprising boswellia species
WO2010130830A3 (en) Anti-sclerostin vhh and their use for treating bone diseases
UA103765C2 (uk) Продукти, що містять декарбоксильовані фенолокислоти, одержані з хлорогенових кислот кави, та їх застосування
DE602007012133D1 (de) Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
WO2007093539A3 (de) Benzoylsubstituierte alanine
WO2006113919A3 (en) Aryl alkyl acid derivatives for and use thereof
WO2008061724A3 (en) Compositions comprising carnosic acid 12-methylether
WO2007095601A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
WO2009027820A3 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
TW200740799A (en) Alpha2C adrenoreceptor agonists
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
EA202091230A3 (ru) Антагонисты активин-actrii и их применения для повышения уровней эритроцитов
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
EP1865967A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND OTHER DISEASES
ATE375164T1 (de) Endotoxin-bindung durch milchsäurebakterien und bifidobacteria
WO2010142551A8 (en) Amino acid sequences directed against receptors to cytokines belonging to the il-17 family
WO2009007411A3 (fr) Inhibition de la formation des ages
WO2009044648A1 (ja) 抗アレルゲン剤
WO2007075439A3 (en) Compositions and methods for treating obesity and related metabolic disorders
ATE499433T1 (de) Geringe mengen hochmolekularer polymere zur viskositätserhöhung bei wässrigen/wässrig- zweiphasigen flüssigkeiten
WO2006128143A3 (en) Hydantoin compounds
WO2011022393A3 (en) Phosphatidylcholine transfer protein inhibitors